June 5, 2022, Cairo, Egypt - Rusatom Healthcare Joint Stock Company (integrator in the field of radiation technologies for medicine and other industries of ROSATOM) and the leading Egyptian pharmaceutical company Pharco Pharmaceuticals signed a Memorandum of Understanding. The Memorandum was signed within the framework of the first Pan-African exhibition and conference Africa Health ExCon 2022, dedicated to the healthcare and pharmaceutical market.

The Memorandum confirmed the intentions of the parties regarding the further development of cooperation and the implementation of joint projects. In particular, the parties agreed to work together on projects of joint development and production of radiopharmaceuticals, conducting pre-clinical, clinical studies, registration and launch of developed products to the market of Egypt, Middle East, Eurasian Economic Union and other countries.

Igor Obrubov, General Director of JSC Rusatom Healthcare, noted: "The radiopharmaceutical industry is one of the most dynamically developing areas in medicine today. The reason for this is the high demand for radiopharmaceuticals by Physicians and patients. Radiotherapy is required for the diagnosis and treatment of about 50% of patients with cancer, and about 20 million new cases are detected annually in the world. In addition, radiopharma is actively used in a number of other nosologies: cardiology, rheumatology, endocrinology. With the development of medical science, this list, I am sure, will expand. I am glad that we have found a partner - Pharco Pharmaceuticals with the like-minded leadership represented by Dr.Sherine Helmy and Pharco’s staff. Together we will be able not only to establish efficient production, but also to develop the new drugs that Physicians and patients around the world are very much waiting for."
Dr. Sherine Helmy, CEO of Pharco Pharmaceuticals, said: “Pharco Pharmaceuticals envisions a great value of cooperation with Rusatom Healthcare in the field of radiopharmaceuticals being a novel field in Egypt with important applications in oncology treatment. We are looking forward to initiate the research and development of new treatment options for oncology patients”.

For reference:
The first Pan-African exhibition and conference Africa Health ExCon 2022, dedicated to the healthcare and pharmaceutical market, is taking place from June 5 to 7 in Cairo, Egypt. The event is held under the patronage of the President of the Arab Republic of Egypt Abdel Fattah El-Sisi and brings together delegates and participants from more than 100 countries.